» Articles » PMID: 31488807

Effects of Cryopreservation on Microparticles Concentration, Procoagulant Function, Size Distribution, and Morphology

Overview
Journal Med Sci Monit
Date 2019 Sep 7
PMID 31488807
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND Research on microparticles is rapidly evolving and has extended to the field of many diseases. It is unclear whether microparticles can be stored frozen. In this study, our goal was to verify whether cryopreservation had an effect on the properties of the microparticles. MATERIAL AND METHODS We obtained C57BL/6J mouse-derived microparticles by grinding and gradient centrifugation. The specimens were divided into 2 groups: without dimethyl sulfoxide and with dimethyl sulfoxide. The microparticles were then stored at 25°C, 4°C, -20°C, -80°C, and -196°C for 0.5 days, 1 day, 3 days, 5 days, and 7 days. We tested whether the concentration, coagulation function, diameter distribution, and morphology of the microparticles in the 2 groups changed compared to those of a fresh sample. RESULTS We discovered that the concentrations of total microparticles, annexin V-positive microparticles, and brain-derived microparticles changed with freezing. The coagulation function, morphology, and size distribution of the microparticles were also affected by cryopreservation. Finally, there was no difference in the effects of cryopreservation on microparticles between the dimethyl sulfoxide group and the dimethyl sulfoxide-free group. CONCLUSIONS This study suggests that cryopreservation has diverse effects on microparticles within 1 week and that dimethyl sulfoxide has no protective effect on cryopreserved microparticles. Therefore, microparticles should be used fresh for future studies, and they should not be cryopreserved with or without dimethyl sulfoxide.

Citing Articles

Prospect of extracellular vesicles in tumor immunotherapy.

Xia W, Tan Y, Liu Y, Xie N, Zhu H Front Immunol. 2025; 16:1525052.

PMID: 40078996 PMC: 11897508. DOI: 10.3389/fimmu.2025.1525052.


Advancements in extracellular vesicles biomanufacturing: a comprehensive overview of large-scale production and clinical research.

Li Z, Yan J, Li X, Chen H, Lin C, Zhang Y Front Bioeng Biotechnol. 2025; 13:1487627.

PMID: 40046812 PMC: 11879961. DOI: 10.3389/fbioe.2025.1487627.


Different storage and freezing protocols for extracellular vesicles: a systematic review.

Ahmadian S, Jafari N, Tamadon A, Ghaffarzadeh A, Rahbarghazi R, Mahdipour M Stem Cell Res Ther. 2024; 15(1):453.

PMID: 39593194 PMC: 11600612. DOI: 10.1186/s13287-024-04005-7.


Roles and therapeutic potential of different extracellular vesicle subtypes on traumatic brain injury.

Dong X, Dong J, Zhang J Cell Commun Signal. 2023; 21(1):211.

PMID: 37596642 PMC: 10436659. DOI: 10.1186/s12964-023-01165-6.


MPs-ACT, an Assay to Evaluate the Procoagulant Activity of Microparticles.

Gao Y, Li X, Qin Y, Men J, Ren J, Li X Clin Appl Thromb Hemost. 2023; 29:10760296231159374.

PMID: 36843474 PMC: 9972054. DOI: 10.1177/10760296231159374.


References
1.
Matsumoto N, Nomura S, Kamihata H, Kimura Y, Iwasaka T . Increased level of oxidized LDL-dependent monocyte-derived microparticles in acute coronary syndrome. Thromb Haemost. 2003; 91(1):146-54. DOI: 10.1160/TH03-04-0247. View

2.
Jy W, Horstman L, Jimenez J, Ahn Y, Biro E, Nieuwland R . Measuring circulating cell-derived microparticles. J Thromb Haemost. 2004; 2(10):1842-51. DOI: 10.1111/j.1538-7836.2004.00936.x. View

3.
Chirinos J, Heresi G, Velasquez H, Jy W, Jimenez J, Ahn E . Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol. 2005; 45(9):1467-71. DOI: 10.1016/j.jacc.2004.12.075. View

4.
Simak J, Gelderman M . Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev. 2005; 20(1):1-26. DOI: 10.1016/j.tmrv.2005.08.001. View

5.
Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P . Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia. 2006; 20(5):847-56. DOI: 10.1038/sj.leu.2404132. View